Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GCK | P35557 | 2/20 | 0.37 |
| ▸ | P2RY14 | Q15391 | 5/20 | 0.35 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.35 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | CCNE1 | P24864 | 2/20 | 0.34 |
| ▸ | CDK2 | P24941 | 2/20 | 0.34 |
| ▸ | CDK5 | Q00535 | 2/20 | 0.34 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.34 |
| ▸ | CDK1 | P06493 | 1/20 | 0.34 |
| ▸ | CDK4 | P11802 | 1/20 | 0.34 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.34 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.34 |
| ▸ | CCND1 | P24385 | 1/20 | 0.34 |
| ▸ | CDK7 | P50613 | 1/20 | 0.34 |
| ▸ | CDK9 | P50750 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24954560 | 0.90 | GCK (0.35) | GCKSMN1; SMN2NPC1TP53RAB9A | |
| SCHEMBL24954289 | 0.89 | RAB9A (0.39) | GCKSMN1; SMN2NPC1RAB9AALDH1A1 | |
| SCHEMBL24952913 | 0.89 | GCK (0.38) | GCKP2RY14SMN1; SMN2ALDH1A1CCNE1 | |
| SCHEMBL24953737 | 0.88 | GCK (0.44) | GCKSMN1; SMN2ALDH1A1CCNE1CDK2 | |
| SCHEMBL24952962 | 0.88 | GCK (0.44) | GCKSMN1; SMN2ALDH1A1CCNE1CDK2 | |
| SCHEMBL24953890 | 0.88 | CCNE1 (0.46) | SMN1; SMN2NPC1TP53RAB9AALDH1A1 | |
| SCHEMBL24952936 | 0.87 | GCK (0.34) | GCKSMN1; SMN2NPC1RAB9AALDH1A1 | |
| SCHEMBL24953934 | 0.87 | CCNE1 (0.38) | SMN1; SMN2NPC1TP53RAB9AALDH1A1 | |
| SCHEMBL24952984 | 0.86 | GAA (0.40) | GCKSMN1; SMN2NPC1TP53RAB9A | |
| SCHEMBL24952914 | 0.85 | ACACB (0.34) | GCKSMN1; SMN2NPC1TP53RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230029266-A1 | MrgprX2 Antagonists for the Treatment of Inflammatory Disorders | DERMIRA, INC. | 2023-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230029266-A1 | MrgprX2 Antagonists for the Treatment of Inflammatory Disorders | MRGPRX2, MRGPRX1, MRGPRX4 | GCK 1519/4885P2RY14 132/4885P2RX3 10/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.